-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $351.00/Share From $370.00 by Leerink Partners

Dow Jones·12/15/2025 20:52:00

登錄查看新聞詳情